Loading…

Characterization of BK Polyomaviruses from Kidney Transplant Recipients Suggests a Role for APOBEC3 in Driving In-Host Virus Evolution

BK polyomavirus (BKV) frequently causes nephropathy (BKVN) in kidney transplant recipients (KTRs). BKV has also been implicated in the etiology of bladder and kidney cancers. We characterized BKV variants from two KTRs who developed BKVN followed by renal carcinoma. Both patients showed a swarm of B...

Full description

Saved in:
Bibliographic Details
Published in:Cell host & microbe 2018-05, Vol.23 (5), p.628-635.e7
Main Authors: Peretti, Alberto, Geoghegan, Eileen M., Pastrana, Diana V., Smola, Sigrun, Feld, Pascal, Sauter, Marlies, Lohse, Stefan, Ramesh, Mayur, Lim, Efrem S., Wang, David, Borgogna, Cinzia, FitzGerald, Peter C., Bliskovsky, Valery, Starrett, Gabriel J., Law, Emily K., Harris, Reuben S., Killian, J. Keith, Zhu, Jack, Pineda, Marbin, Meltzer, Paul S., Boldorini, Renzo, Gariglio, Marisa, Buck, Christopher B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BK polyomavirus (BKV) frequently causes nephropathy (BKVN) in kidney transplant recipients (KTRs). BKV has also been implicated in the etiology of bladder and kidney cancers. We characterized BKV variants from two KTRs who developed BKVN followed by renal carcinoma. Both patients showed a swarm of BKV sequence variants encoding non-silent mutations in surface loops of the viral major capsid protein. The temporal appearance and disappearance of these mutations highlights the intra-patient evolution of BKV. Some of the observed mutations conferred resistance to antibody-mediated neutralization. The mutations also modified the spectrum of receptor glycans engaged by BKV during host cell entry. Intriguingly, all observed mutations were consistent with DNA damage caused by antiviral APOBEC3 cytosine deaminases. Moreover, APOBEC3 expression was evident upon immunohistochemical analysis of renal biopsies from KTRs. These results provide a snapshot of in-host BKV evolution and suggest that APOBEC3 may drive BKV mutagenesis in vivo. [Display omitted] •BKV variants sequenced from kidney transplant patients during development of nephropathy•BKV major capsid protein acquires surface loop mutations over time•Mutations confer resistance to neutralizing antibodies and modify glycan receptor usage•Mutational signatures match APOBEC3 activity, and renal biopsies are positive for APOBEC3 BK polyomavirus causes nephropathy in kidney transplant patients. Peretti et al. show that, during the development of nephropathy, BKV acquires mutations that confer a selective advantage to the virus. The sequence changes are suggestive of a role for cellular APOBEC3 DNA cytosine deaminases in driving BKV mutagenesis in vivo.
ISSN:1931-3128
1934-6069
DOI:10.1016/j.chom.2018.04.005